Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Moringa powder put to the test against metabolic syndrome

NCT ID NCT07194577

Disease control Sponsor: Universidad de Colima Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether taking moringa leaf powder capsules for 8 weeks could improve metabolic syndrome in Mexican adults. 36 participants were randomly assigned to receive either moringa or a placebo. Researchers measured changes in weight, blood pressure, waist size, and blood tests like glucose and cholesterol.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Moringa oleifera dried leaf powder
What this could lead to
If it works, this could point toward a natural supplement to help manage metabolic syndrome, potentially reducing the need for some medications.
What could go wrong
This is a small, early-phase trial with only 36 participants over 8 weeks. Results may not apply to other populations, and the supplement may show no benefit over placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

Jan 2023

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 59 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Beneficiaries of the medical consultation of the Instituto Mexicano del Seguro Social (IMSS), Colima * \- Female and male gender * People with 3 diagnostic variables of metabolic syndrome according to the standardization of criteria established for the diagnosis of Metabolic Syndrome (2009). * Patients under treatment for components of metabolic syndrome (dyslipidemia, diabetes, arterial hypertension) * Signed informed consent Exclusion Criteria: * Conditions that do not allow blood collection * Patients with metabolic syndrome who currently follow a nutritional plan and/or do exercise * Pregnant women * Smokers * Patients with hypothyroidism and hyperthyroidism, cancer, renal failure and/or liver cirrhosis * Patients with any complication of diabetes mellitus * Patients on insulin therapy * People who take botanical extracts or a multivitamin * People with food allergies * Acute infection in progress at the time of blood sample collection * Patients must not be participating in another study alternately Elimination Criteria * Insufficient, coagulated or hemolyzed serum sample. * Patients who interrupt treatment or who do not wish to continue. * Patients who present side effects (nausea, vomiting, diarrhea, stomach pain) or any symptom related to discomfort, allergy or intolerance with the consumption of Moringa oleifera leaf powder that does not disappear in a period of 3 days.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome Dyslipidemias metabolic syndrome X Nutritional and Metabolic Diseases type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metabolic syndrome Nutritional and metabolic diseases

Contacts and locations

Locations

  • Unidad de Medicina Familiar No.19, Instituto Mexicano del Seguro Social

    Colima, Centro, 28000, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.